PT  - JOURNAL ARTICLE
AU  - Alonso, Alvaro
AU  - Alam, Aniqa B.
AU  - Kamel, Hooman
AU  - Subbian, Vignesh
AU  - Qian, Jun
AU  - Boerwinkle, Eric
AU  - Cicek, Mine
AU  - Clark, Cheryl R.
AU  - Cohn, Elizabeth G.
AU  - Gebo, Kelly A.
AU  - Loperena-Cortes, Roxana
AU  - Mayo, Kelsey R.
AU  - Mockrin, Stephen
AU  - Ohno-Machado, Lucila
AU  - Schully, Sheri D.
AU  - Ramirez, Andrea H.
AU  - Greenland, Philip
TI  - Epidemiology of Atrial Fibrillation in the <em>All of Us</em> Research Program
AID  - 10.1101/2021.07.13.21260433
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.13.21260433
4099  - http://medrxiv.org/content/early/2021/07/16/2021.07.13.21260433.short
4100  - http://medrxiv.org/content/early/2021/07/16/2021.07.13.21260433.full
AB  - Background The prevalence, incidence and risk factors of atrial fibrillation (AF) in a large, geographically and ethnically diverse cohort in the United States have not been fully described.Methods We analyzed data from 173,099 participants of the All of Us Research Program recruited in the period 2017-2019, with 92,318 of them having electronic health records (EHR) data available, and 35,483 having completed a medical history survey. Presence of AF at baseline was identified from self-report and EHR records. Incident AF was obtained from EHR. Demographic, anthropometric and clinical risk factors were obtained from questionnaires, baseline physical measurements and EHR.Results At enrollment, mean age was 52 years old (range 18-89). Females and males accounted for 61% and 39% respectively. Non-Hispanic Whites accounted for 67% of participants, with non-Hispanic Blacks, non-Hispanic Asians and Hispanics accounting for 26%, 4% and 3% of participants, respectively. Among 92,318 participants with available EHR data, 3,885 (4.2%) had AF at the time of study enrollment, while the corresponding figure among 35,483 with medical history data was 2,084 (5.9%). During a median follow-up of 16 months, 354 new cases of AF were identified among 88,433 eligible participants. Individuals who were older, male, non-Hispanic white, had higher body mass index, or a prior history of heart failure or coronary heart disease had higher prevalence and incidence of AF.Conclusion The epidemiology of AF in the All of Us Research Program is similar to that reported in smaller studies with careful phenotyping, highlighting the value of this new resource for the study of AF and, potentially, other cardiovascular diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. Research reported in this publication was also supported by the American Heart Association award 16EIA26410001 and the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K24HL148521. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All of Us Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used to conduct this research is available through the All of Us Research Workbench to any individuals who complete the registration process. https://www.researchallofus.org/